Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | 17-AAG | 0.1 | uM | 7 | 2500.00 | 1881.33 | 2053.00 | 3831.50 | 0.5358 | 0.0888 |
| SK-BR-3 | Lapatinib | 0.01 | uM | 7 | 2500.00 | 1881.33 | 3361.00 | 3831.50 | 0.8772 | 0.7603 |
| SK-BR-3 | 0 | uM | 7 | 2500.00 | 1881.33 | 3876.00 | 3831.50 | 1.0116 | 1.0226 | |
| SK-BR-3 | 0 | uM | 7 | 2500.00 | 1881.33 | 2.00 | 3831.50 | 0.0005 | -0.9987 | |
| SK-BR-3 | 0 | uM | 7 | 5000.00 | 1699.69 | 6.00 | 5812.25 | 0.0010 | -0.9586 | |
| SK-BR-3 | 0 | uM | 7 | 5000.00 | 1699.69 | 5251.00 | 5812.25 | 0.9034 | 0.8887 | |
| SK-BR-3 | 0 | uM | 7 | 5000.00 | 1699.69 | 5824.00 | 5812.25 | 1.0020 | 1.0023 | |
| SK-BR-3 | 17-AAG | 3.1623 | uM | 7 | 5000.00 | 1699.69 | 3443.00 | 5812.25 | 0.5924 | 0.4888 |
| SK-BR-3 | Lapatinib | 0.0033113 | uM | 7 | 5000.00 | 1699.69 | 5705.00 | 5812.25 | 0.9816 | 0.9791 |
| SK-BR-3 | Lapatinib | 0.031623 | uM | 7 | 5000.00 | 1699.69 | 4644.00 | 5812.25 | 0.7990 | 0.7624 |
| SK-BR-3 | 17-AAG | 0.0033113 | uM | 7 | 5000.00 | 1699.69 | 5503.00 | 5812.25 | 0.9468 | 0.9393 |
| SK-BR-3 | Linsitinib | 1 | uM | 7 | 5000.00 | 1699.69 | 5164.00 | 5812.25 | 0.8885 | 0.8710 |
| SK-BR-3 | Lapatinib | 0.0016596 | uM | 7 | 5000.00 | 1699.69 | 5767.00 | 5812.25 | 0.9922 | 0.9912 |
| SK-BR-3 | 0 | uM | 7 | 5000.00 | 1699.69 | 5986.00 | 5812.25 | 1.0299 | 1.0335 | |
| SK-BR-3 | Linsitinib | 0.0033113 | uM | 7 | 5000.00 | 1699.69 | 6121.00 | 5812.25 | 1.0531 | 1.0592 |
| SK-BR-3 | Linsitinib | 0.1 | uM | 7 | 5000.00 | 1699.69 | 6399.00 | 5812.25 | 1.1010 | 1.1114 |
| SK-BR-3 | Lapatinib | 0.31623 | uM | 7 | 5000.00 | 1699.69 | 4032.00 | 5812.25 | 0.6937 | 0.6274 |
| SK-BR-3 | Linsitinib | 0.031623 | uM | 7 | 5000.00 | 1699.69 | 5830.00 | 5812.25 | 1.0031 | 1.0034 |
| SK-BR-3 | 17-AAG | 10 | uM | 7 | 5000.00 | 1699.69 | 3458.00 | 5812.25 | 0.5950 | 0.4924 |
| SK-BR-3 | Lapatinib | 0.1 | uM | 7 | 5000.00 | 1699.69 | 4114.00 | 5812.25 | 0.7078 | 0.6460 |
| SK-BR-3 | 17-AAG | 0.31623 | uM | 7 | 5000.00 | 1699.69 | 3638.00 | 5812.25 | 0.6259 | 0.5357 |
| SK-BR-3 | Linsitinib | 10 | uM | 7 | 5000.00 | 1699.69 | 4907.00 | 5812.25 | 0.8443 | 0.8179 |
| SK-BR-3 | Linsitinib | 0.31623 | uM | 7 | 5000.00 | 1699.69 | 5894.00 | 5812.25 | 1.0141 | 1.0158 |
| SK-BR-3 | Erlotinib | 0.31623 | uM | 7 | 5000.00 | 1699.69 | 5863.00 | 5812.25 | 1.0087 | 1.0098 |
| SK-BR-3 | Erlotinib | 3.1623 | uM | 7 | 5000.00 | 1699.69 | 5625.00 | 5812.25 | 0.9678 | 0.9634 |